JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB245118

Anti-CD8 alpha antibody [EPR22483-288]

  • BOND RX™ Validated
  • 20ul selling size
  • Recombinant
  • Advanced Validation
  • RabMAb
  • What is this?

5

(1 Review)

|

(31 Publications)

Anti-CD8 alpha antibody [EPR22483-288] (ab245118) is a rabbit monoclonal antibody detecting CD8 alpha in Flow Cytometry, IP, IHC-P, mIHC. Suitable for Human.

- Multiplex IHC validated on the Leica BOND® MAX using Opal reagents
- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CD8a, MAL, CD8A, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2

10 Images
Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • mIHC

Lab

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Human tonsil staining of PVRIG/CD112R with ab322348 at a 1/100 (5.16 µg/ml) dilution, CD19 with ab320735 at 1/2000 (0.255 µg/ml) dilution and CD8A with ab245118 at 1/1000 ( 0.375 µg/ml) dilution.

Panel A : merged staining of anti-PVRIG/CD112R (green; Opal™520), anti-CD8A (magenta; Opal™570) and anti-CD19 (yellow; Opal™690) on human tonsil.
Panel B : anti-PVRIG/CD112R staining memory and effector CD8+ T lymphocytes in human tonsil.
Panel C : anti-CD8A staining CD8+ T lymphocytes in human tonsil.
Panel D : anti-CD19 staining B lymphocytes in human tonsil.
Nuclear DNA was labeled with DAPI (shown in blue). ).

The section was incubated in three rounds of staining : in the order of ab322348, ab245118 and ab320735 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • mIHC

Lab

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded human liver tissue staining TLR2 with ab325499 at a 1 : 100 (5.0 µg/ml) dilution, ab183322 anti-CD14 used at 1 : 100 (1.22 µg/ml) dilution and ab245118 anti-CD8 alpha used at a 1 : 500 (0.75 µg/ml) dilution.

Panel A : anti-TLR2 (green; Opal™520), anti-CD14 (magenta; Opal™570) and anti-CD8 alpha (yellow; Opal™690) on human liver.
Panel B : anti-TLPR2 staining immune cells in human liver.
Panel C : anti-CD14 staining macrophages in human liver.
Panel D : anti-CD8 alpha staining T lymphocytes in human liver.
Nuclear DNA was labeled with DAPI (shown in blue).

The section was incubated in three rounds of staining : in the order of ab325499, ab183322 and ab245118 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Nuclear counter stain with DAPI.

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • mIHC

Supplier Data

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Human spleen tissue labeling CD8 alpha with ab245118 at 1/500 dilution, CD4 with ab238798 at 1/500, and CD19 with ab237772 at 1/5000 dilution.

Panel A : merged staining of anti-CD8 alpha (magenta; Opal™690), anti-CD4 (green; Opal™520) and anti-CD19 (red; Opal™570) on human spleen.
Panel B : anti-CD8 alpha stained on cytotoxic T cells.
Panel C : anti-CD4 stained on T helper cells.
Panel D : anti-CD19 stained on B cells.

Sections were treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins before antibody incubation. The section was incubated in three rounds of staining : in the order of ab245118 for 30 mins, then ab238798 and ab237772 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

DAPI was used as a nuclear counterstain.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • mIHC

Supplier Data

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Human tonsil tissue labeling CD8 alpha with ab245118 at 1/500 dilution, CD4 with ab238798 at 1/500, and CD19 with ab237772 at 1/5000 dilution.

Panel A : merged staining of anti-CD8 alpha (magenta; Opal™690), anti-CD4 (green; Opal™520) and anti-CD19 (red; Opal™570) on human tonsil.
Panel B : anti-CD8 alpha stained on cytotoxic T cells.
Panel C : anti-CD4 stained on T helper cells.
Panel D : anti-CD19 stained on B cells.

Sections were treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins before antibody incubation. The section was incubated in three rounds of staining : in the order of ab245118 for 30 mins, then ab238798 and ab237772 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

DAPI was used as a nuclear counterstain.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Flow Cytometry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Flow cytometric analysis of human peripheral blood mononuclear cells (PBMC) labeling CD8 alpha with ab245118 at 1/400 (right panel) compared with a Rabbit monoclonal IgG (ab172730) (left panel). Goat anti rabbit IgG (Dylight® 488, ab98462) at 1/2000 dilution was used as the secondary antibody.

Cells were stained with rabbit IgG (Left) or anti-CD8 alpha RabMab (Right). Then stained with Alexa Fluor® 647-conjugated anti-CD4. The expressions of CD4 and CD8 alpha are mutually exclusive.

Gated on viable lymphocytes.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling CD8 alpha with ab245118 at 1/1000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining on the T cell zone of human tonsil (PMID : 16504163) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Immunohistochemical analysis of paraffin-embedded human colon tissue labeling CD8 alpha with ab245118 at 1/1000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining on lymphocytes of human colon (PMID : 26310568) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • mIHC

Lab

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Human colon staining of PVRIG/CD112R with ab322348 at a 1/100 (5.16 µg/ml) dilution, CD19 with ab320735 at 1/2000 (0.255 µg/ml) dilution and CD8A with ab245118 at 1/1000 ( 0.375 µg/ml) dilution.

Panel A : merged staining of anti-PVRIG/CD112R (green; Opal™520), anti-CD8A (magenta; Opal™570) and anti-CD19 (yellow; Opal™690) on Human colon.
Panel B : anti-PVRIG/CD112R staining memory and effector CD8+ T lymphocytes in Human colon.
Panel C : anti-CD8A staining CD8+ T lymphocytes in Human colon.
Panel D : anti-CD19 staining B lymphocytes in Human colon.
Nuclear DNA was labelled with DAPI (shown in blue). ).

The section was incubated in three rounds of staining : in the order of ab322348, ab245118 and ab320735 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • mIHC

Lab

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Human spleen staining of PVRIG/CD112R with ab322348 at a 1/100 (5.16 µg/ml) dilution, CD19 with ab320735 at 1/2000 (0.255 µg/ml) dilution and CD8A with ab245118 at 1/1000 ( 0.375 µg/ml) dilution.

Panel A : merged staining of anti-PVRIG/CD112R (green; Opal™520), anti-CD8A (magenta; Opal™570) and anti-CD19 (yellow; Opal™690) on human spleen.
Panel B : anti-PVRIG/CD112R staining memory and effector CD8+ T lymphocytes in human spleen.
Panel C : anti-CD8A staining CD8+ T lymphocytes in human spleen.
Panel D : anti-CD19 staining B lymphocytes in human spleen.
Nuclear DNA was labelled with DAPI (shown in blue). ).

The section was incubated in three rounds of staining : in the order of ab322348, ab245118 and ab320735 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

Immunoprecipitation - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)
  • IP

Unknown

Immunoprecipitation - Anti-CD8 alpha antibody [EPR22483-288] (AB245118)

CD8 alpha was immunoprecipitated from 0.35 mg human thymus lysate with ab245118 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab245118 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Lane 1 : Human thymus lysate 10 μg (Input).
Lane 2 : ab245118 IP in human thymus lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab245118 in human thymus lysate.

Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.

All lanes:

Immunoprecipitation - Anti-CD8 alpha antibody [EPR22483-288] (ab245118)

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

  • Carrier free

    Anti-CD8 alpha antibody [EPR22483-288] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22483-288

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, IP, Flow Cyt, mIHC

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "mIHC" : {"fullname" : "Multiplex immunohistochemistry", "shortname":"mIHC"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "mIHC-species-checked": "testedAndGuaranteed", "mIHC-species-dilution-info": "1/500", "mIHC-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/400", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-CD8 alpha antibody [EPR22483-288] (ab245118) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Multiplex IHC (mIHC) in Human samples.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR22483-288] also available for your convenience: ab245118, Carrier free - ab245830

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD8 alpha also known as CD8A or CD8 protein is a glycoprotein subunit expressed on the surface of cytotoxic T lymphocytes. It has a mass of approximately 32 kDa. Found on the surface cell membrane CD8 alpha functions primarily in the immune response specifically in the recognition of antigens bound to major histocompatibility complex (MHC) class I molecules. Often scientists use CD8 antibodies for detection and CD8 IHC or immunohistochemistry for localization studies.
Biological function summary

The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.

Pathways

CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha's role in adaptive immunity.

CD8 alpha is most prominently associated with viral infections and cancer. Conditions like HIV and some forms of leukemia show altered CD8 function highlighting the protein's role in immune surveillance. In HIV infection for instance CD8 T cells reduce in number impairing the immune response. CD8 alpha's connection to the immune system places it alongside other immune proteins such as CD4 and MHC molecules in the context of immune dysfunction.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the gene CD8A is an integral membrane glycoprotein crucial for immune responses, operating mainly in T-cells as a coreceptor for MHC class I molecule : peptide complexes. These peptides originate from cytosolic proteins, unlike class II peptides, which are from extracellular proteins. CD8A interacts with the T-cell receptor (TCR) and MHC class I proteins on antigen-presenting cells, recruiting the Src kinase LCK to the TCR-CD3 complex. LCK phosphorylates substrates, triggering signaling pathways that lead to the production of lymphokines, enhanced motility, adhesion, and activation of cytotoxic T-lymphocytes (CTLs), thereby aiding in the recognition and elimination of infected or tumor cells. Additionally, in natural killer (NK) cells, CD8A homodimers on the cell surface provide a survival mechanism for conjugating with and lysing multiple target cells. CD8A homodimers also facilitate the survival and differentiation of activated lymphocytes into memory CD8 T-cells. This supplementary information is collated from multiple sources and compiled automatically.
See full target information CD8A

Publications (31)

Recent publications for all applications. Explore the full list and refine your search

Clinical and translational medicine 15:e70464 PubMed40985995

2025

CD103CD8 tissue-resident memory T lymphocytes of melanoma boost anti-tumour immunity and predict immunotherapy outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Tianyi Zhang,Junquan Song,Yinlam Li,Kangjie Shen,Jiangying Xuan,Yuan Gao,Lili Lu,Zhi Pang,Lu Wang,Yang Yang,Zixu Gao,Qianrong Hu,Yu Zhu,Chenlu Wei,Shaoluan Zheng,Rongkui Luo,Yingyong Hou,Yuhong Zhou,Chuanyuan Wei,Jianying Gu

Frontiers in oncology 15:1636367 PubMed40951359

2025

Claudin18.2 defines a prognostically distinct subgroup of intrahepatic cholangiocarcinoma via CD8 T-cell exclusion.

Applications

Unspecified application

Species

Unspecified reactive species

Chengui Yu,Yuren Pan,Fuli Li,Zhenyun Guo,Da Xu,Ying Zhu,Baobing Yin

Oncology research 33:2379-2398 PubMed40918458

2025

Suppresses Colorectal Cancer Progression by Inhibiting Epithelial-Mesenchymal Transition via Regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Yuhang Jiang,Yijun Xu,Qi Zhu,Yingxia Wu,Zhe Wang,Shuang He,Shiyong Yu,Honggang Xiang

BMC gastroenterology 25:513 PubMed40640712

2025

The prognostic value of immunoscore in the early-onset colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xinchun Wu,Sen Hou,Yingjiang Ye,Zhidong Gao

BMC gastroenterology 25:435 PubMed40481392

2025

ZBTB10 as a potential prognosis biomarker and correlates with the tumor immune microenvironment in stomach adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yingdi Jiang,Fuhua Han,Lu Dai,Shali Qiu,Yanjie Zhou,Ke Wang,Jiang Lin

Cancer immunology, immunotherapy : CII 74:213 PubMed40402312

2025

Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC.

Applications

Unspecified application

Species

Unspecified reactive species

Qianqian Zhang,Guoxin Wang,Wenjie Yan,Dong Wang,Jie Yin,Yong Song,Mingxiang Ye,Tangfeng Lv

Journal of translational medicine 23:478 PubMed40281576

2025

scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ziqi Huang,Li Li,Xiaohe Zhao,Haixia Jin,Meng Shen,Baihui Li,Yu Zeng,Qinfen Zhang,Qiyu Wang,Meng Wang,Lili Yang

Microbiology spectrum :e0283024 PubMed40202312

2025

Prognostic implications of the interaction between intratumoral microbiome and immune response in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sifan Liu,Lingyu Qi,Lu Dong,Wenjing Sun,Siying Liu,Peng Li,Nan Zhang

Nature communications 16:1425 PubMed39915478

2025

Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Xiong,Linpeng Yao,Jinglai Lin,Jiaxi Yao,Qi Bai,Yuan Huang,Xue Zhang,Risheng Huang,Run Wang,Kang Wang,Yu Qi,Pingyi Zhu,Haoran Wang,Li Liu,Jianjun Zhou,Jianming Guo,Feng Chen,Chenchen Dai,Shuo Wang

Translational oncology 53:102210 PubMed39874729

2025

LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

YaoBang Liu,Hong Li,DaHai Chai,Bin Lian,ZhengYang Bai,YaLi Gao,JinPing Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com